Source: Advances in therapy. Unidade: FM
Subjects: CARDIOLOGIA, LIPOPROTEÍNAS, PEDIATRIA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEN-OMRAN, Tawfeg et al. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia. Advances in therapy, v. 36, n. 7, p. 1786-1811, 2019Tradução . . Disponível em: https://doi.org/10.1007/s12325-019-00985-8. Acesso em: 15 out. 2024.APA
Ben-omran, T., Masana, L., Kolovou, G., Ariceta, G., Novoa, F. J., Lund, A. M., et al. (2019). Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia. Advances in therapy, 36( 7), 1786-1811. doi:10.1007/s12325-019-00985-8NLM
Ben-omran T, Masana L, Kolovou G, Ariceta G, Novoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Santos Filho RD dos. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia [Internet]. Advances in therapy. 2019 ; 36( 7): 1786-1811.[citado 2024 out. 15 ] Available from: https://doi.org/10.1007/s12325-019-00985-8Vancouver
Ben-omran T, Masana L, Kolovou G, Ariceta G, Novoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Santos Filho RD dos. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia [Internet]. Advances in therapy. 2019 ; 36( 7): 1786-1811.[citado 2024 out. 15 ] Available from: https://doi.org/10.1007/s12325-019-00985-8